Trial Profile
Phase II study of with a variant AdCOVID vaccine
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 22 May 2021
Price :
$35
*
At a glance
- Drugs Coronavirus vaccine-Altimmune (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 22 May 2021 New trial record
- 17 May 2021 According to an Altimmune media release, the company expect to initiate this trial in the Q4 2021.